FIELD: pharmaceutics.
SUBSTANCE: invention relates to pharmaceutical industry, specifically to use of polysaccharide hydrolyzate tansy habitus as a transporter protein inhibitor glycoprotein-P. Application of hydrolyzate of polysaccharide complex of flowers tansy with a molecular weight of 3.8 kDa, produced method for acid hydrolysis of tansy flowers with 0.1 M sulfuric acid for 3 hours, as a transporter protein inhibitor glycoprotein-P.
EFFECT: obtained hydrolyzate in vitro tests inhibits activity Pgp, and by severity of effect it is comparable to classic inhibitor of transporter protein verapamil.
1 cl, 1 dwg, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR INHIBITION OF GLYCOPROTEIN-P IN AN IN VITRO EXPERIMENT | 2021 |
|
RU2779177C1 |
| METHOD TO MODEL CONDITION OF INHIBITION OF FUNCTIONAL ACTIVITY OF GLYCOPROTEIN-P BY LYNESTRENOL IN TRIAL | 2014 |
|
RU2553362C1 |
| METHOD OF ABCB1 PROTEIN INHIBITION IN EXPERIMENT IN VITRO | 2023 |
|
RU2811993C1 |
| MEANS FOR REDUCTION OF GLYCOPROTEIN-P FUNCTIONAL ACTIVITY AND EXPRESSION | 2017 |
|
RU2649134C1 |
| METHOD FOR ASSESSING THE FUNCTIONAL ACTIVITY OF GLYCOPROTEIN-P IN THE BLOOD-BRAIN BARRIER | 2018 |
|
RU2677286C1 |
| METHOD FOR EXPERIMENTAL FINASTERIDE SIMULATION OF INDUCTION OF FUNCTIONAL ACTIVITY OF GLYCOPROTEIN-P | 2012 |
|
RU2504018C1 |
| METHOD OF DETERMINING FUNCTIONAL ACTIVITY OF GLYCOPROTEIN-P | 2015 |
|
RU2587780C1 |
| INHIBITOR OF ATP-DEPENDENT REVERSE CELL TRANSPORTERS AND METHOD FOR ITS PRODUCTION | 2016 |
|
RU2641304C1 |
| METHOD FOR DETERMINING INDIVIDUAL SOLID HUMAN TUMOR SENSITIVITY TO CHEMOTHERAPY | 2005 |
|
RU2315997C2 |
| METHOD FOR SIMULATING INHIBITION STATE OF FUNCTIONAL ACTIVITY OF GLYCOPROTEIN-P WITH DIPEPTIDYL PEPTIDASE 4 INHIBITOR | 2015 |
|
RU2602688C1 |
